文献速递瓣膜外科

机械瓣与生物瓣二尖瓣置换:倾向性评分匹配的生存与再手术分析

Mechanical versus biological mitral valve replacement: Insights from propensity score matching on survival and reoperation rates.
PubMed 文献 · J Thorac Cardiovasc Surg · 2024-07-26

该单中心回顾性研究纳入2001至2020年行二尖瓣置换的2027例患者,其中生物瓣1658例、机械瓣369例,经倾向性评分匹配后各339对。

要点

  • 该研究为单中心回顾性设计,随访中位时间6.83年。

核心结论

  • 在高容量中心20年随访中,机械瓣与生物瓣二尖瓣置换的生存率相当,而机械瓣置换后的再手术率显著更低。

研究设计与样本

  • 单中心回顾性研究,纳入2001至2020年所有行二尖瓣置换的患者2027例,其中生物瓣1658例、机械瓣369例,51.2%为男性,手术年龄65.9±12.9岁。
  • 采用倾向性评分匹配调整年龄、性别、体重、身高、心内膜炎、糖尿病、高血压、外周动脉闭塞性疾病、心房颤动、慢性肾脏病、癌症及神经系统疾病史,匹配后得到339对。
  • 中位随访时间6.83年(四分位距1.11-10.61年),1467例(72.4%)同期行合并手术。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Patients with symptomatic mitral valve disease unsuitable for repair can be sufficiently treated with surgical mitral valve replacement. The decision between biological and mechanical mitral valve replacement can be difficult, especially due to the question of the lesser of 2 evils: anticoagulation versus reoperation. METHODS: This single-center, retrospective study included all patients undergoing mitral valve replacement between 2001 and 2020. Thirty-day mortality and periprocedural complications were analyzed. Propensity score matching adjusted for age, gender, weight, height, endocarditis, diabetes, hypertension, peripheral arterial occlusive disease, atrial fibrillation, chronic kidney disease, cancer, and history of neurological disorders was performed. After propensity score matching, survival and cumulative incidence of reoperation at time of follow-up were analyzed. RESULTS: The study included 2027 patients in 2 main groups: 1658 patients with biological mitral valve replacement and 369 patients with mechanical mitral valve replacement; 51.2% were male. Age at surgery was 65.9 ± 12.9 years. Median follow-up time was 6.83 years (interquartile range, 1.11-10.61 years). Concomitant procedures were performed in 1467 cases (72.4%). Propensity score matching yielded comparable groups of 339 pairs. Both groups showed comparable survival (P = .203). Survival after mechanical mitral valve replacement and biological mitral valve replacement was comparable for all analyzed time points over the course of 20 years. Patients with mechanical mitral valve replacement showed a significantly lower cumulative incidence for reoperation (20 years: 15% vs 59%, P < .001). CONCLUSIONS: Follow-up of 20 years at a high-volume center demonstrates comparable survival after mechanical or biological mitral valve replacement, whereas reoperation rates are significantly lower after mechanical mitral valve replacement.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Feirer N, Buchner A, Weber M, et al. Mechanical versus biological mitral valve replacement: Insights from propensity score matching on survival and reoperation rates. J Thorac Cardiovasc Surg. 2024. PMID: 39067811. doi:10.1016/j.jtcvs.2024.07.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。